This study presents a novel strategy to treat pulmonary tuberculosis using inhalable polymer nanoparticles.

The paper highlights:

• A dry powder formulation for deep lung delivery
• Controlled and sustained release of N-acetylcysteine (NAC)
• Improved lung deposition and particle flowability
• A superior antibacterial activity against Mycobacterium tuberculosis

This work is the result of an international collaboration, aiming to improve tuberculosis therapy with more effective and patient-friendly solutions.

We extend our congratulations to all the authors for their contribution to this high-impact research. See more.